Abstract
Circulating tumor cells (CTCs) have emerged as a viable solution to the lack of tumor tissue availability for patients with a variety of solid tumors, including prostate cancer. Different approaches have been used to capture this tumor cell population and several of these techniques have been used to assess the potential role of CTCs as a biological marker to predict treatment efficacy and clinical outcome. CTCs are now considered a strong tool to understand the molecular characteristics of prostate cancer, and to be used and analyzed as a 'liquid biopsy' in the attempt to grasp the biological portrait of the disease in the individual patient.
| Original language | English |
|---|---|
| Pages (from-to) | 389-402 |
| Number of pages | 14 |
| Journal | Molecular Diagnosis and Therapy |
| Volume | 18 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2014 |
Fingerprint
ASJC Scopus subject areas
- Genetics
- Molecular Medicine
- Medicine(all)
- Pharmacology
Cite this
Circulating tumor cells in prostate cancer diagnosis and monitoring : An appraisal of clinical potential. / Galletti, Giuseppe; Portella, Luigi; Tagawa, Scott T.; Kirby, Brian J.; Giannakakou, Paraskevi; Nanus, David M.
In: Molecular Diagnosis and Therapy, Vol. 18, No. 4, 2014, p. 389-402.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Circulating tumor cells in prostate cancer diagnosis and monitoring
T2 - An appraisal of clinical potential
AU - Galletti, Giuseppe
AU - Portella, Luigi
AU - Tagawa, Scott T.
AU - Kirby, Brian J.
AU - Giannakakou, Paraskevi
AU - Nanus, David M.
PY - 2014
Y1 - 2014
N2 - Circulating tumor cells (CTCs) have emerged as a viable solution to the lack of tumor tissue availability for patients with a variety of solid tumors, including prostate cancer. Different approaches have been used to capture this tumor cell population and several of these techniques have been used to assess the potential role of CTCs as a biological marker to predict treatment efficacy and clinical outcome. CTCs are now considered a strong tool to understand the molecular characteristics of prostate cancer, and to be used and analyzed as a 'liquid biopsy' in the attempt to grasp the biological portrait of the disease in the individual patient.
AB - Circulating tumor cells (CTCs) have emerged as a viable solution to the lack of tumor tissue availability for patients with a variety of solid tumors, including prostate cancer. Different approaches have been used to capture this tumor cell population and several of these techniques have been used to assess the potential role of CTCs as a biological marker to predict treatment efficacy and clinical outcome. CTCs are now considered a strong tool to understand the molecular characteristics of prostate cancer, and to be used and analyzed as a 'liquid biopsy' in the attempt to grasp the biological portrait of the disease in the individual patient.
UR - http://www.scopus.com/inward/record.url?scp=84905683195&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84905683195&partnerID=8YFLogxK
U2 - 10.1007/s40291-014-0101-8
DO - 10.1007/s40291-014-0101-8
M3 - Article
VL - 18
SP - 389
EP - 402
JO - Molecular Diagnosis and Therapy
JF - Molecular Diagnosis and Therapy
SN - 1177-1062
IS - 4
ER -